Tuberculosis (TB) remains a significant global health challenge, being one of the leading causes of death from infectious diseases. The causative agent, ...
tuberculosis can survive for years (latent infection). They fall into a permanently inactive state with reduced metabolic activity and can thus not be completely eliminated by the immune system. As ...
Genome variation in both humans and TB bacteria may affect different phenotype and treatment. This large-scale study will analyze the variation of both host and pathogen genomes among TB patients, ...
Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...
whooping cough and tuberculosis. The new approach uses samples from infected humans to allow real-time monitoring of pathogens circulating in human populations, and enable vaccine-evading bugs to ...